Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Revenue Recognition - Disaggregation of Revenue (Details)

v3.20.4
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue $ 444,448 $ 408,830 $ 276,741
Clinical Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue 382,337 361,161 241,873
Pharma Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue 62,111 47,669 34,868
Client direct billing | Clinical Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue 240,535 212,703 164,888
Commercial insurance | Clinical Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue 76,550 83,107 40,360
Medicare and other government | Clinical Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue 64,776 64,745 35,566
Self-Pay | Clinical Services      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Total net revenue $ 476 $ 606 $ 1,059